These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 36834570

  • 1. Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.
    Eldosoky MA, Hammad R, Elmadbouly AA, Aglan RB, Abdel-Hamid SG, Alboraie M, Hassan DA, Shaheen MA, Rushdi A, Ahmed RM, Abdelbadea A, Abdelmageed NA, Elshafei A, Ali E, Abo-Elkheir OI, Zaky S, Hamdy NM, Lambert C.
    Int J Mol Sci; 2023 Feb 05; 24(4):. PubMed ID: 36834570
    [Abstract] [Full Text] [Related]

  • 2. Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma.
    Hammad R, Eldosoky MA, Elmadbouly AA, Aglan RB, AbdelHamid SG, Zaky S, Ali E, Abd El Hakam FE, Mosaad AM, Abdelmageed NA, Kotb FM, Kotb HG, Hady AA, Abo-Elkheir OI, Kujumdshiev S, Sack U, Lambert C, Hamdy NM.
    J Cancer Res Clin Oncol; 2023 Nov 05; 149(17):15349-15364. PubMed ID: 37639012
    [Abstract] [Full Text] [Related]

  • 3. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA.
    Tumour Biol; 2016 Sep 05; 37(9):12273-12286. PubMed ID: 27271989
    [Abstract] [Full Text] [Related]

  • 4. Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma.
    Yasser MB, Abdellatif M, Emad E, Jafer A, Ahmed S, Nageb L, Abdelshafy H, Al-Anany AM, Al-Arab MAE, Gibriel AA.
    Virus Res; 2021 Apr 15; 296():198341. PubMed ID: 33607184
    [Abstract] [Full Text] [Related]

  • 5. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME.
    Mol Diagn Ther; 2015 Aug 15; 19(4):213-20. PubMed ID: 26133725
    [Abstract] [Full Text] [Related]

  • 6. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S, Bhowmik S, Majumdar S, Goswami A, Chakraborty J, Gupta S, Aggarwal S, Ray S, Chatterjee R, Bhattacharyya S, Dutta M, Datta S, Chowdhury A, Dhali GK, Banerjee S.
    Int J Cancer; 2020 Nov 15; 147(10):2934-2947. PubMed ID: 32441313
    [Abstract] [Full Text] [Related]

  • 7. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH, Zayed N, Riad NM, Tamim HH, Shahin RMH, Labib DA, ELsheikh SM, Moneim RA, Yosry A, Khalifa RH.
    Virus Res; 2018 Aug 15; 255():77-84. PubMed ID: 30003924
    [Abstract] [Full Text] [Related]

  • 8. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS, Elgendy NA, Tawfik NA, Elnasser AM.
    Egypt J Immunol; 2019 Jul 15; 26(2):31-40. PubMed ID: 31926493
    [Abstract] [Full Text] [Related]

  • 9. Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis.
    Machida M, Ambo M, Mishina R, Hada N, Tachibana F, Yamashita M, Konda A, Tsuji K.
    Technol Cancer Res Treat; 2023 Jul 15; 22():15330338231212084. PubMed ID: 37960842
    [Abstract] [Full Text] [Related]

  • 10. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
    Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X, Zhou X, Gan J.
    PLoS One; 2014 Jul 15; 9(9):e107986. PubMed ID: 25238238
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
    Malik J, Klammer M, Rolny V, Chan HL, Piratvisuth T, Tanwandee T, Thongsawat S, Sukeepaisarnjaroen W, Esteban JI, Bes M, Köhler B, Swiatek-de Lange M.
    World J Gastroenterol; 2022 Aug 07; 28(29):3917-3933. PubMed ID: 36157551
    [Abstract] [Full Text] [Related]

  • 12. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
    Wang Z, Gao P, Sun W, Rehman AU, Jiang J, Xu S, Xue C, Zhu C, Qin X.
    Front Endocrinol (Lausanne); 2023 Aug 07; 14():938102. PubMed ID: 36793272
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.
    Tan Y, Lin B, Ye Y, Wen D, Chen L, Zhou X.
    Oncol Rep; 2015 Jun 07; 33(6):2863-70. PubMed ID: 25962820
    [Abstract] [Full Text] [Related]

  • 14. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y, Zhang C, Zhang P, Guo G, Jiang T, Zhao X, Jiang J, Huang X, Tong H, Tian Y.
    Cancer Med; 2018 May 07; 7(5):1670-1679. PubMed ID: 29573235
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH.
    World J Gastroenterol; 2019 Nov 14; 25(42):6322-6341. PubMed ID: 31754293
    [Abstract] [Full Text] [Related]

  • 16. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L, Wang Y, Wang D, Han G, Fu S, Wang J.
    PLoS One; 2017 Nov 14; 12(9):e0183880. PubMed ID: 28902891
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA, Lee JS, Jung ES, Kim JY, Bae WK, Kim NH, Moon YS.
    Korean J Gastroenterol; 2006 Nov 14; 48(5):321-6. PubMed ID: 17132920
    [Abstract] [Full Text] [Related]

  • 19. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.
    Morita K, Shirabe K, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Ikegami T, Yamashita Y, Sugimachi K, Harimoto N, Itoh S, Ikeda T, Maehara Y.
    Liver Transpl; 2016 May 14; 22(5):665-76. PubMed ID: 26783726
    [Abstract] [Full Text] [Related]

  • 20. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X, Gao J, Zhou B, Xie J, Zhou G, Chen Y.
    Life Sci; 2019 Sep 01; 232():116596. PubMed ID: 31233760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.